LiuyanJiangMD

Pathology • Jacksonville, FL

Hematopathology, Anatomic Pathology, Clinical Pathology

Assistant Professor, Laboratory Medicine & Pathology, Mayo Medical School

Join to view full profile

Dr. Jiang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jiang's full profile

Already have an account?

Office
4500 San Pablo Rd S
Jacksonville, FL 32224
Phone+1 904-953-2000

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematopathology, 2006 - 2008
University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2005 - 2006
University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 2001 - 2005
Shanghai Medical UniversityClass of 1993

Certifications & Licensure

FL State Medical License 2008 - 2026
TX State Medical License 2008 - 2026
GA State Medical License 2013 - 2017
AL State Medical License 2005 - 2012
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Hematopathology

Publications & Presentations

PubMed

47 citations
Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma.
Rebecca A. Luchtel, Michael T. Zimmermann, Guangzhen Hu, Surendra Dasari, Manli Jiang
Blood. 2019-06-27
91 citations
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.
Rebecca A. Luchtel, Surendra Dasari, Naoki Oishi, Martin Bjerregård Pedersen, Guangzhen Hu
Blood. 2018-09-27
317 citations
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar, Elaine S. Jaffe, Jonathan W. Said, Steven H. Swerdlow, Rhett P. Ketterling
Blood. 2014-08-28

Journal Articles

Targeting CD38 with Daratumumab Is Lethal to Waldenström Macroglobulinaemia Cells
Richard Furman, Stephen M Ansell, Sikander Ailawadhi, Thomas E Witzig, Vivek Roy, Taimur Sher, Liuyan Jiang, British Journal of Haematology

Press Mentions

Primary Peritoneal Myeloid Sarcoma in Association with CBFB/MYH11 FusionMarch 16th, 2021